Integration of听AI听technology in听cancer听care could improve the accuracy and speed of diagnosis, aid clinical decision-making, and lead to better health outcomes.听AI-guided clinical care has the potential to play an important role in reducing health disparities, particularly in low-resource settings.
Market Analysis and Insights: Global Artificial Intelligence (AI) in Cancer Market
The global Artificial Intelligence (AI) in Cancer market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Artificial Intelligence (AI) in Cancer is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Artificial Intelligence (AI) in Cancer is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Artificial Intelligence (AI) in Cancer is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key companies of Artificial Intelligence (AI) in Cancer include IBM, Microsoft, NVIDIA, Intel, GE Healthcare, Johnson & Johnson, Cancer Center.ai, Digital Reasoning and Varian Medical Systems, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Artificial Intelligence (AI) in Cancer market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Artificial Intelligence (AI) in Cancer, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Artificial Intelligence (AI) in Cancer, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Artificial Intelligence (AI) in Cancer revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Artificial Intelligence (AI) in Cancer market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Artificial Intelligence (AI) in Cancer revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including IBM, Microsoft, NVIDIA, Intel, GE Healthcare, Johnson & Johnson, Cancer Center.ai, Digital Reasoning and Varian Medical Systems, etc.
By Company
IBM
Microsoft
NVIDIA
Intel
GE Healthcare
Johnson & Johnson
Cancer Center.ai
Digital Reasoning
Varian Medical Systems
Niramai
Densitas
MammoScreen
MVision AI
Volpara
LungLifeAI
Segment by Type
Surgery
Radiotherapy
Chemotherapy
Immunotherapy
Phototherapy
Gene Therapy
Sonodynamic Therapy
Segment by Application
Diagnosis
Therapy
Prognosis
Health Management
Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Artificial Intelligence (AI) in Cancer in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Intelligence (AI) in Cancer companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artificial Intelligence (AI) in Cancer revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Surgery
1.2.3 Radiotherapy
1.2.4 Chemotherapy
1.2.5 Immunotherapy
1.2.6 Phototherapy
1.2.7 Gene Therapy
1.2.8 Sonodynamic Therapy
1.3 Market by Application
1.3.1 Global Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Diagnosis
1.3.3 Therapy
1.3.4 Prognosis
1.3.5 Health Management
1.3.6 Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Intelligence (AI) in Cancer Market Perspective (2018-2029)
2.2 Global Artificial Intelligence (AI) in Cancer Growth Trends by Region
2.2.1 Artificial Intelligence (AI) in Cancer Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Artificial Intelligence (AI) in Cancer Historic Market Size by Region (2018-2023)
2.2.3 Artificial Intelligence (AI) in Cancer Forecasted Market Size by Region (2024-2029)
2.3 Artificial Intelligence (AI) in Cancer Market Dynamics
2.3.1 Artificial Intelligence (AI) in Cancer Industry Trends
2.3.2 Artificial Intelligence (AI) in Cancer Market Drivers
2.3.3 Artificial Intelligence (AI) in Cancer Market Challenges
2.3.4 Artificial Intelligence (AI) in Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Artificial Intelligence (AI) in Cancer by Players
3.1.1 Global Artificial Intelligence (AI) in Cancer Revenue by Players (2018-2023)
3.1.2 Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Players (2018-2023)
3.2 Global Artificial Intelligence (AI) in Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Artificial Intelligence (AI) in Cancer, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Artificial Intelligence (AI) in Cancer Market Concentration Ratio
3.4.1 Global Artificial Intelligence (AI) in Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence (AI) in Cancer Revenue in 2022
3.5 Global Key Players of Artificial Intelligence (AI) in Cancer Head office and Area Served
3.6 Global Key Players of Artificial Intelligence (AI) in Cancer, Product and Application
3.7 Global Key Players of Artificial Intelligence (AI) in Cancer, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Intelligence (AI) in Cancer Breakdown Data by Type
4.1 Global Artificial Intelligence (AI) in Cancer Historic Market Size by Type (2018-2023)
4.2 Global Artificial Intelligence (AI) in Cancer Forecasted Market Size by Type (2024-2029)
5 Artificial Intelligence (AI) in Cancer Breakdown Data by Application
5.1 Global Artificial Intelligence (AI) in Cancer Historic Market Size by Application (2018-2023)
5.2 Global Artificial Intelligence (AI) in Cancer Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Artificial Intelligence (AI) in Cancer Market Size (2018-2029)
6.2 North America Artificial Intelligence (AI) in Cancer Market Size by Type
6.2.1 North America Artificial Intelligence (AI) in Cancer Market Size by Type (2018-2023)
6.2.2 North America Artificial Intelligence (AI) in Cancer Market Size by Type (2024-2029)
6.2.3 North America Artificial Intelligence (AI) in Cancer Market Share by Type (2018-2029)
6.3 North America Artificial Intelligence (AI) in Cancer Market Size by Application
6.3.1 North America Artificial Intelligence (AI) in Cancer Market Size by Application (2018-2023)
6.3.2 North America Artificial Intelligence (AI) in Cancer Market Size by Application (2024-2029)
6.3.3 North America Artificial Intelligence (AI) in Cancer Market Share by Application (2018-2029)
6.4 North America Artificial Intelligence (AI) in Cancer Market Size by Country
6.4.1 North America Artificial Intelligence (AI) in Cancer Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Artificial Intelligence (AI) in Cancer Market Size by Country (2018-2023)
6.4.3 North America Artificial Intelligence (AI) in Cancer Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Artificial Intelligence (AI) in Cancer Market Size (2018-2029)
7.2 Europe Artificial Intelligence (AI) in Cancer Market Size by Type
7.2.1 Europe Artificial Intelligence (AI) in Cancer Market Size by Type (2018-2023)
7.2.2 Europe Artificial Intelligence (AI) in Cancer Market Size by Type (2024-2029)
7.2.3 Europe Artificial Intelligence (AI) in Cancer Market Share by Type (2018-2029)
7.3 Europe Artificial Intelligence (AI) in Cancer Market Size by Application
7.3.1 Europe Artificial Intelligence (AI) in Cancer Market Size by Application (2018-2023)
7.3.2 Europe Artificial Intelligence (AI) in Cancer Market Size by Application (2024-2029)
7.3.3 Europe Artificial Intelligence (AI) in Cancer Market Share by Application (2018-2029)
7.4 Europe Artificial Intelligence (AI) in Cancer Market Size by Country
7.4.1 Europe Artificial Intelligence (AI) in Cancer Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Artificial Intelligence (AI) in Cancer Market Size by Country (2018-2023)
7.4.3 Europe Artificial Intelligence (AI) in Cancer Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Artificial Intelligence (AI) in Cancer Market Size (2018-2029)
8.2 China Artificial Intelligence (AI) in Cancer Market Size by Type
8.2.1 China Artificial Intelligence (AI) in Cancer Market Size by Type (2018-2023)
8.2.2 China Artificial Intelligence (AI) in Cancer Market Size by Type (2024-2029)
8.2.3 China Artificial Intelligence (AI) in Cancer Market Share by Type (2018-2029)
8.3 China Artificial Intelligence (AI) in Cancer Market Size by Application
8.3.1 China Artificial Intelligence (AI) in Cancer Market Size by Application (2018-2023)
8.3.2 China Artificial Intelligence (AI) in Cancer Market Size by Application (2024-2029)
8.3.3 China Artificial Intelligence (AI) in Cancer Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Artificial Intelligence (AI) in Cancer Market Size (2018-2029)
9.2 Asia Artificial Intelligence (AI) in Cancer Market Size by Type
9.2.1 Asia Artificial Intelligence (AI) in Cancer Market Size by Type (2018-2023)
9.2.2 Asia Artificial Intelligence (AI) in Cancer Market Size by Type (2024-2029)
9.2.3 Asia Artificial Intelligence (AI) in Cancer Market Share by Type (2018-2029)
9.3 Asia Artificial Intelligence (AI) in Cancer Market Size by Application
9.3.1 Asia Artificial Intelligence (AI) in Cancer Market Size by Application (2018-2023)
9.3.2 Asia Artificial Intelligence (AI) in Cancer Market Size by Application (2024-2029)
9.3.3 Asia Artificial Intelligence (AI) in Cancer Market Share by Application (2018-2029)
9.4 Asia Artificial Intelligence (AI) in Cancer Market Size by Region
9.4.1 Asia Artificial Intelligence (AI) in Cancer Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Artificial Intelligence (AI) in Cancer Market Size by Region (2018-2023)
9.4.3 Asia Artificial Intelligence (AI) in Cancer Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Type
10.2.1 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Application
10.3.1 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Country
10.4.1 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Artificial Intelligence (AI) in Cancer Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 IBM
11.1.1 IBM Company Details
11.1.2 IBM Business Overview
11.1.3 IBM Artificial Intelligence (AI) in Cancer Introduction
11.1.4 IBM Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.1.5 IBM Recent Developments
11.2 Microsoft
11.2.1 Microsoft Company Details
11.2.2 Microsoft Business Overview
11.2.3 Microsoft Artificial Intelligence (AI) in Cancer Introduction
11.2.4 Microsoft Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.2.5 Microsoft Recent Developments
11.3 NVIDIA
11.3.1 NVIDIA Company Details
11.3.2 NVIDIA Business Overview
11.3.3 NVIDIA Artificial Intelligence (AI) in Cancer Introduction
11.3.4 NVIDIA Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.3.5 NVIDIA Recent Developments
11.4 Intel
11.4.1 Intel Company Details
11.4.2 Intel Business Overview
11.4.3 Intel Artificial Intelligence (AI) in Cancer Introduction
11.4.4 Intel Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.4.5 Intel Recent Developments
11.5 GE Healthcare
11.5.1 GE Healthcare Company Details
11.5.2 GE Healthcare Business Overview
11.5.3 GE Healthcare Artificial Intelligence (AI) in Cancer Introduction
11.5.4 GE Healthcare Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.5.5 GE Healthcare Recent Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Artificial Intelligence (AI) in Cancer Introduction
11.6.4 Johnson & Johnson Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.6.5 Johnson & Johnson Recent Developments
11.7 Cancer Center.ai
11.7.1 Cancer Center.ai Company Details
11.7.2 Cancer Center.ai Business Overview
11.7.3 Cancer Center.ai Artificial Intelligence (AI) in Cancer Introduction
11.7.4 Cancer Center.ai Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.7.5 Cancer Center.ai Recent Developments
11.8 Digital Reasoning
11.8.1 Digital Reasoning Company Details
11.8.2 Digital Reasoning Business Overview
11.8.3 Digital Reasoning Artificial Intelligence (AI) in Cancer Introduction
11.8.4 Digital Reasoning Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.8.5 Digital Reasoning Recent Developments
11.9 Varian Medical Systems
11.9.1 Varian Medical Systems Company Details
11.9.2 Varian Medical Systems Business Overview
11.9.3 Varian Medical Systems Artificial Intelligence (AI) in Cancer Introduction
11.9.4 Varian Medical Systems Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.9.5 Varian Medical Systems Recent Developments
11.10 Niramai
11.10.1 Niramai Company Details
11.10.2 Niramai Business Overview
11.10.3 Niramai Artificial Intelligence (AI) in Cancer Introduction
11.10.4 Niramai Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.10.5 Niramai Recent Developments
11.11 Densitas
11.11.1 Densitas Company Details
11.11.2 Densitas Business Overview
11.11.3 Densitas Artificial Intelligence (AI) in Cancer Introduction
11.11.4 Densitas Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.11.5 Densitas Recent Developments
11.12 MammoScreen
11.12.1 MammoScreen Company Details
11.12.2 MammoScreen Business Overview
11.12.3 MammoScreen Artificial Intelligence (AI) in Cancer Introduction
11.12.4 MammoScreen Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.12.5 MammoScreen Recent Developments
11.13 MVision AI
11.13.1 MVision AI Company Details
11.13.2 MVision AI Business Overview
11.13.3 MVision AI Artificial Intelligence (AI) in Cancer Introduction
11.13.4 MVision AI Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.13.5 MVision AI Recent Developments
11.14 Volpara
11.14.1 Volpara Company Details
11.14.2 Volpara Business Overview
11.14.3 Volpara Artificial Intelligence (AI) in Cancer Introduction
11.14.4 Volpara Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.14.5 Volpara Recent Developments
11.15 LungLifeAI
11.15.1 LungLifeAI Company Details
11.15.2 LungLifeAI Business Overview
11.15.3 LungLifeAI Artificial Intelligence (AI) in Cancer Introduction
11.15.4 LungLifeAI Revenue in Artificial Intelligence (AI) in Cancer Business (2018-2023)
11.15.5 LungLifeAI Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
IBM
Microsoft
NVIDIA
Intel
GE Healthcare
Johnson & Johnson
Cancer Center.ai
Digital Reasoning
Varian Medical Systems
Niramai
Densitas
MammoScreen
MVision AI
Volpara
LungLifeAI
听
听
*If Applicable.
